Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
35 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: Semaglutide;   Drug: Dulaglutide
22 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/Lixisenatide (HOE901/AVE0010);   Drug: Lixisenatide (AVE0010);   Drug: Oral anti-diabetic drugs
23 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/lixisenatide (HOE901/AVE0010);   Drug: Insulin glargine (HOE901);   Drug: Oral anti-diabetic drugs
24 Recruiting A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: INSULIN GLARGINE (U300);   Drug: metformin;   Drug: sulfonylurea;   Drug: meglitinides;   Drug: thiazolidinediones;   Drug: alpha-glucosidase inhibitors;   Drug: GLP1 Receptor Agonist;   Drug: Dipeptidyl peptidase-IV (DPP-IV) inhibitors;   Drug: Sodium-glucose transport-2 (SGLT-2) inhibitors
25 Not yet recruiting Hypoglycemia Prediction Model
Condition: Hypoglycemia
Intervention: Other: Hypoglycemia prediction alert
26 Recruiting Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: INSULIN GLARGINE
27 Recruiting Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Behavioral: Active titration algorithm;   Behavioral: Usual titration algorithm
28 Recruiting Acute Liver Injury in Patients on Dapagliflozin
Condition: Acute Liver Injury
Intervention:
29 Recruiting A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Dulaglutide;   Drug: Placebo
30 Recruiting Complications of UTI in Patients on Dapagliflozin
Condition: Severe Complications of Urinary Tract Infections
Intervention:
31 Recruiting The Hellenic Postprandial Lipemia Study (HPLS)
Conditions: Coronary Heart Disease;   Dyslipidemia
Intervention:
32 Recruiting Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome (PCOS)
Interventions: Drug: DLBS3233;   Drug: Metformin XR;   Drug: Placebo caplet of Metformin XR;   Drug: Placebo capsule of DLBS3233
33 Recruiting Safety and Efficacy of Liraglutide in Parkinson's Disease
Condition: Parkinson Disease
Interventions: Drug: Liraglutide;   Drug: Placebo
34 Recruiting Metformin Use in Chronic Kidney Disease: The CKD-Met Study
Conditions: Type 2 Diabetes;   Chronic Kidney Disease
Intervention: Other: modalities of metformin prescription
35 Recruiting Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Welchol for oral suspension placebo proxy;   Drug: Welchol for oral suspension

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Study has passed its completion date and status has not been verified in more than two years.